Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy

Nahla A Azzam; Abdulelah Almutairdi; Hajer Y Almudaiheem; Turki AlAmeel; Shakir A Bakkari; Othman R Alharbi; Khalidah A Alenzi; Maha A AlMolaiki; Bedor A Al-Omari; Rayan G Albarakati; Ahmed H Al-Jedai; Omar I Saadah; Majid A Almadi; Badr Al-Bawardy; Mahmoud H Mosli

doi:10.4103/sjg.sjg_318_23

Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy

Saudi J Gastroenterol. 2023 Dec 15. doi: 10.4103/sjg.sjg_318_23. Online ahead of print.

Authors

Nahla A Azzam¹, Abdulelah Almutairdi², Hajer Y Almudaiheem³, Turki AlAmeel⁴, Shakir A Bakkari⁵, Othman R Alharbi¹, Khalidah A Alenzi⁶, Maha A AlMolaiki^{7

8

9}, Bedor A Al-Omari¹⁰, Rayan G Albarakati¹¹, Ahmed H Al-Jedai^{3

12}, Omar I Saadah¹³, Majid A Almadi¹, Badr Al-Bawardy^{2

14}, Mahmoud H Mosli¹⁵

Affiliations

¹ Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
² Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
³ Deputyship of Therapeutic Affairs, Ministry of Health, Riyadh, Saudi Arabia.
⁴ Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
⁵ Department of Gastroenterology, King Saud Medical City, Riyadh, Saudi Arabia.
⁶ Executive Director of Transformation, Planning, and Business Development, Tabuk Health Cluster, Tabuk, Saudi Arabia.
⁷ Department of Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
⁸ King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
⁹ Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
¹⁰ Department of Pharmaceutical Care Services, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
¹¹ Department of Obstetrics and Gynecology, Majmaah University, Riyadh, Saudi Arabia.
¹² Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.
¹³ Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
¹⁴ Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA.
¹⁵ Department of Internal Medicine, King Abdulaziz University, Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

PMID: 38099556
DOI: 10.4103/sjg.sjg_318_23

Abstract

The management of inflammatory bowel disease (IBD) in pregnant women is challenging and must be addressed on a patient-by-patient basis. Optimal patient management requires a multidisciplinary team and clear evidence-based recommendations that cater to this subset of patients. In this article, we provide concise guidelines and clinical care pathway for the management of IBD in pregnant women. Our recommendations were developed by a multidisciplinary working group that includes experts from the Saudi Ministry of Health in collaboration with the Saudi Gastroenterology Association and the Saudi Society of Clinical Pharmacology. All recommendations are based on up-to-date information following an extensive literature review. A total of 23 evidence-based expert opinion recommendations for the management of IBD in pregnant women are herein provided.